MARKET

VXRT

VXRT

VAXART
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3131
-0.0069
-2.16%
After Hours: 0.3200 +0.0069 +2.20% 17:43 12/13 EST
OPEN
0.3190
PREV CLOSE
0.3200
HIGH
0.3200
LOW
0.3012
VOLUME
115.41K
TURNOVER
--
52 WEEK HIGH
5.00
52 WEEK LOW
0.2543
MARKET CAP
14.47M
P/E (TTM)
-0.1983
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VXRT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VXRT News

  • Vaxart EPS beats by $0.03, beats on revenue
  • seekingalpha.11/13 02:49
  • Vaxart Q3 EPS $(0.32) Up From $(0.92) YoY, Sales $454K Up From $281K YoY
  • Benzinga.11/12 21:54
  • Vaxart Announces Third Quarter 2019 Financial Results and Provides Corporate Update
  • GlobeNewswire.11/12 21:45
  • Key events next week - healthcare
  • Seeking Alpha - Article.11/08 15:48

More

Industry

Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About VXRT

Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. It has preclinical RSV non-fusion inhibitor program. It has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.
More

Webull offers Vaxart Inc (VXRT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.